Global Toxoid Vaccines Market Growth 2025-2031
The global Toxoid Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
United States market for Toxoid Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Toxoid Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Toxoid Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Toxoid Vaccines players cover GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Toxoid Vaccines Industry Forecast” looks at past sales and reviews total world Toxoid Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Toxoid Vaccines sales for 2025 through 2031. With Toxoid Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Toxoid Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Toxoid Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Toxoid Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Toxoid Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Toxoid Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Toxoid Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Toxoid Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Toxoid Vaccines market?
What factors are driving Toxoid Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Toxoid Vaccines market opportunities vary by end market size?
How does Toxoid Vaccines break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
United States market for Toxoid Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Toxoid Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Toxoid Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Toxoid Vaccines players cover GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Toxoid Vaccines Industry Forecast” looks at past sales and reviews total world Toxoid Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Toxoid Vaccines sales for 2025 through 2031. With Toxoid Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Toxoid Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Toxoid Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Toxoid Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Toxoid Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Toxoid Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Toxoid Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Toxoid Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monovalent Tetanus Toxoid (TT)
- Diphtheria
- Tetanus
- Pertussis (DTaP)
- Diphtheria and Tetanus (DT)
- Hospitals and Clinics
- Government Organizations
- Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi Pasteur
- AstraZeneca
- Bharat Biotech
- Shenzhen Kangtai Biological Products
- Bausch Health
- Emergent Biosolutions
- Astellas Pharma
- Panacea Biotec
What is the 10-year outlook for the global Toxoid Vaccines market?
What factors are driving Toxoid Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Toxoid Vaccines market opportunities vary by end market size?
How does Toxoid Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Toxoid Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Toxoid Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Toxoid Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Toxoid Vaccines Segment by Type
2.2.1 Monovalent Tetanus Toxoid (TT)
2.2.2 Diphtheria
2.2.3 Tetanus
2.2.4 Pertussis (DTaP)
2.2.5 Diphtheria and Tetanus (DT)
2.3 Toxoid Vaccines Sales by Type
2.3.1 Global Toxoid Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Toxoid Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Toxoid Vaccines Sale Price by Type (2020-2025)
2.4 Toxoid Vaccines Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Government Organizations
2.4.3 Research
2.4.4 Others
2.5 Toxoid Vaccines Sales by Application
2.5.1 Global Toxoid Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Toxoid Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Toxoid Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Toxoid Vaccines Breakdown Data by Company
3.1.1 Global Toxoid Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Toxoid Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Toxoid Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Toxoid Vaccines Revenue by Company (2020-2025)
3.2.2 Global Toxoid Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Toxoid Vaccines Sale Price by Company
3.4 Key Manufacturers Toxoid Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Toxoid Vaccines Product Location Distribution
3.4.2 Players Toxoid Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TOXOID VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Toxoid Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Toxoid Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Toxoid Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Toxoid Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Toxoid Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Toxoid Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Toxoid Vaccines Sales Growth
4.4 APAC Toxoid Vaccines Sales Growth
4.5 Europe Toxoid Vaccines Sales Growth
4.6 Middle East & Africa Toxoid Vaccines Sales Growth
5 AMERICAS
5.1 Americas Toxoid Vaccines Sales by Country
5.1.1 Americas Toxoid Vaccines Sales by Country (2020-2025)
5.1.2 Americas Toxoid Vaccines Revenue by Country (2020-2025)
5.2 Americas Toxoid Vaccines Sales by Type (2020-2025)
5.3 Americas Toxoid Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Toxoid Vaccines Sales by Region
6.1.1 APAC Toxoid Vaccines Sales by Region (2020-2025)
6.1.2 APAC Toxoid Vaccines Revenue by Region (2020-2025)
6.2 APAC Toxoid Vaccines Sales by Type (2020-2025)
6.3 APAC Toxoid Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Toxoid Vaccines by Country
7.1.1 Europe Toxoid Vaccines Sales by Country (2020-2025)
7.1.2 Europe Toxoid Vaccines Revenue by Country (2020-2025)
7.2 Europe Toxoid Vaccines Sales by Type (2020-2025)
7.3 Europe Toxoid Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Toxoid Vaccines by Country
8.1.1 Middle East & Africa Toxoid Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Toxoid Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Toxoid Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Toxoid Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Toxoid Vaccines
10.3 Manufacturing Process Analysis of Toxoid Vaccines
10.4 Industry Chain Structure of Toxoid Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Toxoid Vaccines Distributors
11.3 Toxoid Vaccines Customer
12 WORLD FORECAST REVIEW FOR TOXOID VACCINES BY GEOGRAPHIC REGION
12.1 Global Toxoid Vaccines Market Size Forecast by Region
12.1.1 Global Toxoid Vaccines Forecast by Region (2026-2031)
12.1.2 Global Toxoid Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Toxoid Vaccines Forecast by Type (2026-2031)
12.7 Global Toxoid Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Toxoid Vaccines Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Toxoid Vaccines Product Portfolios and Specifications
13.2.3 Merck Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Toxoid Vaccines Product Portfolios and Specifications
13.3.3 Pfizer Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sanofi Pasteur
13.4.1 Sanofi Pasteur Company Information
13.4.2 Sanofi Pasteur Toxoid Vaccines Product Portfolios and Specifications
13.4.3 Sanofi Pasteur Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sanofi Pasteur Main Business Overview
13.4.5 Sanofi Pasteur Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Toxoid Vaccines Product Portfolios and Specifications
13.5.3 AstraZeneca Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Toxoid Vaccines Product Portfolios and Specifications
13.6.3 Bharat Biotech Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Shenzhen Kangtai Biological Products
13.7.1 Shenzhen Kangtai Biological Products Company Information
13.7.2 Shenzhen Kangtai Biological Products Toxoid Vaccines Product Portfolios and Specifications
13.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shenzhen Kangtai Biological Products Main Business Overview
13.7.5 Shenzhen Kangtai Biological Products Latest Developments
13.8 Bausch Health
13.8.1 Bausch Health Company Information
13.8.2 Bausch Health Toxoid Vaccines Product Portfolios and Specifications
13.8.3 Bausch Health Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bausch Health Main Business Overview
13.8.5 Bausch Health Latest Developments
13.9 Emergent Biosolutions
13.9.1 Emergent Biosolutions Company Information
13.9.2 Emergent Biosolutions Toxoid Vaccines Product Portfolios and Specifications
13.9.3 Emergent Biosolutions Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Emergent Biosolutions Main Business Overview
13.9.5 Emergent Biosolutions Latest Developments
13.10 Astellas Pharma
13.10.1 Astellas Pharma Company Information
13.10.2 Astellas Pharma Toxoid Vaccines Product Portfolios and Specifications
13.10.3 Astellas Pharma Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Astellas Pharma Main Business Overview
13.10.5 Astellas Pharma Latest Developments
13.11 Panacea Biotec
13.11.1 Panacea Biotec Company Information
13.11.2 Panacea Biotec Toxoid Vaccines Product Portfolios and Specifications
13.11.3 Panacea Biotec Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Panacea Biotec Main Business Overview
13.11.5 Panacea Biotec Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Toxoid Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Toxoid Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Toxoid Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Toxoid Vaccines Segment by Type
2.2.1 Monovalent Tetanus Toxoid (TT)
2.2.2 Diphtheria
2.2.3 Tetanus
2.2.4 Pertussis (DTaP)
2.2.5 Diphtheria and Tetanus (DT)
2.3 Toxoid Vaccines Sales by Type
2.3.1 Global Toxoid Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Toxoid Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Toxoid Vaccines Sale Price by Type (2020-2025)
2.4 Toxoid Vaccines Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Government Organizations
2.4.3 Research
2.4.4 Others
2.5 Toxoid Vaccines Sales by Application
2.5.1 Global Toxoid Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Toxoid Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Toxoid Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Toxoid Vaccines Breakdown Data by Company
3.1.1 Global Toxoid Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Toxoid Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Toxoid Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Toxoid Vaccines Revenue by Company (2020-2025)
3.2.2 Global Toxoid Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Toxoid Vaccines Sale Price by Company
3.4 Key Manufacturers Toxoid Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Toxoid Vaccines Product Location Distribution
3.4.2 Players Toxoid Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TOXOID VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Toxoid Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Toxoid Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Toxoid Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Toxoid Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Toxoid Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Toxoid Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Toxoid Vaccines Sales Growth
4.4 APAC Toxoid Vaccines Sales Growth
4.5 Europe Toxoid Vaccines Sales Growth
4.6 Middle East & Africa Toxoid Vaccines Sales Growth
5 AMERICAS
5.1 Americas Toxoid Vaccines Sales by Country
5.1.1 Americas Toxoid Vaccines Sales by Country (2020-2025)
5.1.2 Americas Toxoid Vaccines Revenue by Country (2020-2025)
5.2 Americas Toxoid Vaccines Sales by Type (2020-2025)
5.3 Americas Toxoid Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Toxoid Vaccines Sales by Region
6.1.1 APAC Toxoid Vaccines Sales by Region (2020-2025)
6.1.2 APAC Toxoid Vaccines Revenue by Region (2020-2025)
6.2 APAC Toxoid Vaccines Sales by Type (2020-2025)
6.3 APAC Toxoid Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Toxoid Vaccines by Country
7.1.1 Europe Toxoid Vaccines Sales by Country (2020-2025)
7.1.2 Europe Toxoid Vaccines Revenue by Country (2020-2025)
7.2 Europe Toxoid Vaccines Sales by Type (2020-2025)
7.3 Europe Toxoid Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Toxoid Vaccines by Country
8.1.1 Middle East & Africa Toxoid Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Toxoid Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Toxoid Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Toxoid Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Toxoid Vaccines
10.3 Manufacturing Process Analysis of Toxoid Vaccines
10.4 Industry Chain Structure of Toxoid Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Toxoid Vaccines Distributors
11.3 Toxoid Vaccines Customer
12 WORLD FORECAST REVIEW FOR TOXOID VACCINES BY GEOGRAPHIC REGION
12.1 Global Toxoid Vaccines Market Size Forecast by Region
12.1.1 Global Toxoid Vaccines Forecast by Region (2026-2031)
12.1.2 Global Toxoid Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Toxoid Vaccines Forecast by Type (2026-2031)
12.7 Global Toxoid Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Toxoid Vaccines Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Toxoid Vaccines Product Portfolios and Specifications
13.2.3 Merck Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Toxoid Vaccines Product Portfolios and Specifications
13.3.3 Pfizer Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sanofi Pasteur
13.4.1 Sanofi Pasteur Company Information
13.4.2 Sanofi Pasteur Toxoid Vaccines Product Portfolios and Specifications
13.4.3 Sanofi Pasteur Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sanofi Pasteur Main Business Overview
13.4.5 Sanofi Pasteur Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Toxoid Vaccines Product Portfolios and Specifications
13.5.3 AstraZeneca Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Toxoid Vaccines Product Portfolios and Specifications
13.6.3 Bharat Biotech Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Shenzhen Kangtai Biological Products
13.7.1 Shenzhen Kangtai Biological Products Company Information
13.7.2 Shenzhen Kangtai Biological Products Toxoid Vaccines Product Portfolios and Specifications
13.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shenzhen Kangtai Biological Products Main Business Overview
13.7.5 Shenzhen Kangtai Biological Products Latest Developments
13.8 Bausch Health
13.8.1 Bausch Health Company Information
13.8.2 Bausch Health Toxoid Vaccines Product Portfolios and Specifications
13.8.3 Bausch Health Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bausch Health Main Business Overview
13.8.5 Bausch Health Latest Developments
13.9 Emergent Biosolutions
13.9.1 Emergent Biosolutions Company Information
13.9.2 Emergent Biosolutions Toxoid Vaccines Product Portfolios and Specifications
13.9.3 Emergent Biosolutions Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Emergent Biosolutions Main Business Overview
13.9.5 Emergent Biosolutions Latest Developments
13.10 Astellas Pharma
13.10.1 Astellas Pharma Company Information
13.10.2 Astellas Pharma Toxoid Vaccines Product Portfolios and Specifications
13.10.3 Astellas Pharma Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Astellas Pharma Main Business Overview
13.10.5 Astellas Pharma Latest Developments
13.11 Panacea Biotec
13.11.1 Panacea Biotec Company Information
13.11.2 Panacea Biotec Toxoid Vaccines Product Portfolios and Specifications
13.11.3 Panacea Biotec Toxoid Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Panacea Biotec Main Business Overview
13.11.5 Panacea Biotec Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Toxoid Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Toxoid Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monovalent Tetanus Toxoid (TT)
Table 4. Major Players of Diphtheria
Table 5. Major Players of Tetanus
Table 6. Major Players of Pertussis (DTaP)
Table 7. Major Players of Diphtheria and Tetanus (DT)
Table 8. Global Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 9. Global Toxoid Vaccines Sales Market Share by Type (2020-2025)
Table 10. Global Toxoid Vaccines Revenue by Type (2020-2025) & ($ million)
Table 11. Global Toxoid Vaccines Revenue Market Share by Type (2020-2025)
Table 12. Global Toxoid Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Toxoid Vaccines Sale by Application (2020-2025) & (K Units)
Table 14. Global Toxoid Vaccines Sale Market Share by Application (2020-2025)
Table 15. Global Toxoid Vaccines Revenue by Application (2020-2025) & ($ million)
Table 16. Global Toxoid Vaccines Revenue Market Share by Application (2020-2025)
Table 17. Global Toxoid Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Toxoid Vaccines Sales by Company (2020-2025) & (K Units)
Table 19. Global Toxoid Vaccines Sales Market Share by Company (2020-2025)
Table 20. Global Toxoid Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Toxoid Vaccines Revenue Market Share by Company (2020-2025)
Table 22. Global Toxoid Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Toxoid Vaccines Producing Area Distribution and Sales Area
Table 24. Players Toxoid Vaccines Products Offered
Table 25. Toxoid Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Toxoid Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Toxoid Vaccines Sales Market Share Geographic Region (2020-2025)
Table 30. Global Toxoid Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Toxoid Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Toxoid Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Toxoid Vaccines Sales Market Share by Country/Region (2020-2025)
Table 34. Global Toxoid Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Toxoid Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Toxoid Vaccines Sales by Country (2020-2025) & (K Units)
Table 37. Americas Toxoid Vaccines Sales Market Share by Country (2020-2025)
Table 38. Americas Toxoid Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 40. Americas Toxoid Vaccines Sales by Application (2020-2025) & (K Units)
Table 41. APAC Toxoid Vaccines Sales by Region (2020-2025) & (K Units)
Table 42. APAC Toxoid Vaccines Sales Market Share by Region (2020-2025)
Table 43. APAC Toxoid Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 45. APAC Toxoid Vaccines Sales by Application (2020-2025) & (K Units)
Table 46. Europe Toxoid Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Europe Toxoid Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 49. Europe Toxoid Vaccines Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Toxoid Vaccines Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Toxoid Vaccines Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Toxoid Vaccines Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Toxoid Vaccines
Table 55. Key Market Challenges & Risks of Toxoid Vaccines
Table 56. Key Industry Trends of Toxoid Vaccines
Table 57. Toxoid Vaccines Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Toxoid Vaccines Distributors List
Table 60. Toxoid Vaccines Customer List
Table 61. Global Toxoid Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Toxoid Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Toxoid Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Toxoid Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Toxoid Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Toxoid Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Toxoid Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Toxoid Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Toxoid Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Toxoid Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Toxoid Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Toxoid Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Toxoid Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Toxoid Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. GlaxoSmithKline Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 76. GlaxoSmithKline Toxoid Vaccines Product Portfolios and Specifications
Table 77. GlaxoSmithKline Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Latest Developments
Table 80. Merck Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Toxoid Vaccines Product Portfolios and Specifications
Table 82. Merck Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. Pfizer Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Toxoid Vaccines Product Portfolios and Specifications
Table 87. Pfizer Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Sanofi Pasteur Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Pasteur Toxoid Vaccines Product Portfolios and Specifications
Table 92. Sanofi Pasteur Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi Pasteur Main Business
Table 94. Sanofi Pasteur Latest Developments
Table 95. AstraZeneca Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. AstraZeneca Toxoid Vaccines Product Portfolios and Specifications
Table 97. AstraZeneca Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. AstraZeneca Main Business
Table 99. AstraZeneca Latest Developments
Table 100. Bharat Biotech Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Bharat Biotech Toxoid Vaccines Product Portfolios and Specifications
Table 102. Bharat Biotech Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Bharat Biotech Main Business
Table 104. Bharat Biotech Latest Developments
Table 105. Shenzhen Kangtai Biological Products Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Shenzhen Kangtai Biological Products Toxoid Vaccines Product Portfolios and Specifications
Table 107. Shenzhen Kangtai Biological Products Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Shenzhen Kangtai Biological Products Main Business
Table 109. Shenzhen Kangtai Biological Products Latest Developments
Table 110. Bausch Health Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. Bausch Health Toxoid Vaccines Product Portfolios and Specifications
Table 112. Bausch Health Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Bausch Health Main Business
Table 114. Bausch Health Latest Developments
Table 115. Emergent Biosolutions Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. Emergent Biosolutions Toxoid Vaccines Product Portfolios and Specifications
Table 117. Emergent Biosolutions Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Emergent Biosolutions Main Business
Table 119. Emergent Biosolutions Latest Developments
Table 120. Astellas Pharma Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Astellas Pharma Toxoid Vaccines Product Portfolios and Specifications
Table 122. Astellas Pharma Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Astellas Pharma Main Business
Table 124. Astellas Pharma Latest Developments
Table 125. Panacea Biotec Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Panacea Biotec Toxoid Vaccines Product Portfolios and Specifications
Table 127. Panacea Biotec Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Panacea Biotec Main Business
Table 129. Panacea Biotec Latest Developments
Table 1. Toxoid Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Toxoid Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monovalent Tetanus Toxoid (TT)
Table 4. Major Players of Diphtheria
Table 5. Major Players of Tetanus
Table 6. Major Players of Pertussis (DTaP)
Table 7. Major Players of Diphtheria and Tetanus (DT)
Table 8. Global Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 9. Global Toxoid Vaccines Sales Market Share by Type (2020-2025)
Table 10. Global Toxoid Vaccines Revenue by Type (2020-2025) & ($ million)
Table 11. Global Toxoid Vaccines Revenue Market Share by Type (2020-2025)
Table 12. Global Toxoid Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Toxoid Vaccines Sale by Application (2020-2025) & (K Units)
Table 14. Global Toxoid Vaccines Sale Market Share by Application (2020-2025)
Table 15. Global Toxoid Vaccines Revenue by Application (2020-2025) & ($ million)
Table 16. Global Toxoid Vaccines Revenue Market Share by Application (2020-2025)
Table 17. Global Toxoid Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Toxoid Vaccines Sales by Company (2020-2025) & (K Units)
Table 19. Global Toxoid Vaccines Sales Market Share by Company (2020-2025)
Table 20. Global Toxoid Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Toxoid Vaccines Revenue Market Share by Company (2020-2025)
Table 22. Global Toxoid Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Toxoid Vaccines Producing Area Distribution and Sales Area
Table 24. Players Toxoid Vaccines Products Offered
Table 25. Toxoid Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Toxoid Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Toxoid Vaccines Sales Market Share Geographic Region (2020-2025)
Table 30. Global Toxoid Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Toxoid Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Toxoid Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Toxoid Vaccines Sales Market Share by Country/Region (2020-2025)
Table 34. Global Toxoid Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Toxoid Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Toxoid Vaccines Sales by Country (2020-2025) & (K Units)
Table 37. Americas Toxoid Vaccines Sales Market Share by Country (2020-2025)
Table 38. Americas Toxoid Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 40. Americas Toxoid Vaccines Sales by Application (2020-2025) & (K Units)
Table 41. APAC Toxoid Vaccines Sales by Region (2020-2025) & (K Units)
Table 42. APAC Toxoid Vaccines Sales Market Share by Region (2020-2025)
Table 43. APAC Toxoid Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 45. APAC Toxoid Vaccines Sales by Application (2020-2025) & (K Units)
Table 46. Europe Toxoid Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Europe Toxoid Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 49. Europe Toxoid Vaccines Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Toxoid Vaccines Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Toxoid Vaccines Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Toxoid Vaccines Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Toxoid Vaccines Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Toxoid Vaccines
Table 55. Key Market Challenges & Risks of Toxoid Vaccines
Table 56. Key Industry Trends of Toxoid Vaccines
Table 57. Toxoid Vaccines Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Toxoid Vaccines Distributors List
Table 60. Toxoid Vaccines Customer List
Table 61. Global Toxoid Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Toxoid Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Toxoid Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Toxoid Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Toxoid Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Toxoid Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Toxoid Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Toxoid Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Toxoid Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Toxoid Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Toxoid Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Toxoid Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Toxoid Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Toxoid Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. GlaxoSmithKline Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 76. GlaxoSmithKline Toxoid Vaccines Product Portfolios and Specifications
Table 77. GlaxoSmithKline Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Latest Developments
Table 80. Merck Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Toxoid Vaccines Product Portfolios and Specifications
Table 82. Merck Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. Pfizer Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Toxoid Vaccines Product Portfolios and Specifications
Table 87. Pfizer Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Sanofi Pasteur Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Pasteur Toxoid Vaccines Product Portfolios and Specifications
Table 92. Sanofi Pasteur Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi Pasteur Main Business
Table 94. Sanofi Pasteur Latest Developments
Table 95. AstraZeneca Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. AstraZeneca Toxoid Vaccines Product Portfolios and Specifications
Table 97. AstraZeneca Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. AstraZeneca Main Business
Table 99. AstraZeneca Latest Developments
Table 100. Bharat Biotech Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Bharat Biotech Toxoid Vaccines Product Portfolios and Specifications
Table 102. Bharat Biotech Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Bharat Biotech Main Business
Table 104. Bharat Biotech Latest Developments
Table 105. Shenzhen Kangtai Biological Products Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Shenzhen Kangtai Biological Products Toxoid Vaccines Product Portfolios and Specifications
Table 107. Shenzhen Kangtai Biological Products Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Shenzhen Kangtai Biological Products Main Business
Table 109. Shenzhen Kangtai Biological Products Latest Developments
Table 110. Bausch Health Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. Bausch Health Toxoid Vaccines Product Portfolios and Specifications
Table 112. Bausch Health Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Bausch Health Main Business
Table 114. Bausch Health Latest Developments
Table 115. Emergent Biosolutions Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. Emergent Biosolutions Toxoid Vaccines Product Portfolios and Specifications
Table 117. Emergent Biosolutions Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Emergent Biosolutions Main Business
Table 119. Emergent Biosolutions Latest Developments
Table 120. Astellas Pharma Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Astellas Pharma Toxoid Vaccines Product Portfolios and Specifications
Table 122. Astellas Pharma Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Astellas Pharma Main Business
Table 124. Astellas Pharma Latest Developments
Table 125. Panacea Biotec Basic Information, Toxoid Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Panacea Biotec Toxoid Vaccines Product Portfolios and Specifications
Table 127. Panacea Biotec Toxoid Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Panacea Biotec Main Business
Table 129. Panacea Biotec Latest Developments
LIST OF FIGURES
Figure 1. Picture of Toxoid Vaccines
Figure 2. Toxoid Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Toxoid Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Toxoid Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Toxoid Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Toxoid Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Toxoid Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monovalent Tetanus Toxoid (TT)
Figure 12. Product Picture of Diphtheria
Figure 13. Product Picture of Tetanus
Figure 14. Product Picture of Pertussis (DTaP)
Figure 15. Product Picture of Diphtheria and Tetanus (DT)
Figure 16. Global Toxoid Vaccines Sales Market Share by Type in 2025
Figure 17. Global Toxoid Vaccines Revenue Market Share by Type (2020-2025)
Figure 18. Toxoid Vaccines Consumed in Hospitals and Clinics
Figure 19. Global Toxoid Vaccines Market: Hospitals and Clinics (2020-2025) & (K Units)
Figure 20. Toxoid Vaccines Consumed in Government Organizations
Figure 21. Global Toxoid Vaccines Market: Government Organizations (2020-2025) & (K Units)
Figure 22. Toxoid Vaccines Consumed in Research
Figure 23. Global Toxoid Vaccines Market: Research (2020-2025) & (K Units)
Figure 24. Toxoid Vaccines Consumed in Others
Figure 25. Global Toxoid Vaccines Market: Others (2020-2025) & (K Units)
Figure 26. Global Toxoid Vaccines Sale Market Share by Application (2024)
Figure 27. Global Toxoid Vaccines Revenue Market Share by Application in 2025
Figure 28. Toxoid Vaccines Sales by Company in 2025 (K Units)
Figure 29. Global Toxoid Vaccines Sales Market Share by Company in 2025
Figure 30. Toxoid Vaccines Revenue by Company in 2025 ($ millions)
Figure 31. Global Toxoid Vaccines Revenue Market Share by Company in 2025
Figure 32. Global Toxoid Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Toxoid Vaccines Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Toxoid Vaccines Sales 2020-2025 (K Units)
Figure 35. Americas Toxoid Vaccines Revenue 2020-2025 ($ millions)
Figure 36. APAC Toxoid Vaccines Sales 2020-2025 (K Units)
Figure 37. APAC Toxoid Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Europe Toxoid Vaccines Sales 2020-2025 (K Units)
Figure 39. Europe Toxoid Vaccines Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Toxoid Vaccines Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Toxoid Vaccines Revenue 2020-2025 ($ millions)
Figure 42. Americas Toxoid Vaccines Sales Market Share by Country in 2025
Figure 43. Americas Toxoid Vaccines Revenue Market Share by Country (2020-2025)
Figure 44. Americas Toxoid Vaccines Sales Market Share by Type (2020-2025)
Figure 45. Americas Toxoid Vaccines Sales Market Share by Application (2020-2025)
Figure 46. United States Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Toxoid Vaccines Sales Market Share by Region in 2025
Figure 51. APAC Toxoid Vaccines Revenue Market Share by Region (2020-2025)
Figure 52. APAC Toxoid Vaccines Sales Market Share by Type (2020-2025)
Figure 53. APAC Toxoid Vaccines Sales Market Share by Application (2020-2025)
Figure 54. China Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. India Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Toxoid Vaccines Sales Market Share by Country in 2025
Figure 62. Europe Toxoid Vaccines Revenue Market Share by Country (2020-2025)
Figure 63. Europe Toxoid Vaccines Sales Market Share by Type (2020-2025)
Figure 64. Europe Toxoid Vaccines Sales Market Share by Application (2020-2025)
Figure 65. Germany Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. France Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Toxoid Vaccines Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Toxoid Vaccines Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Toxoid Vaccines Sales Market Share by Application (2020-2025)
Figure 73. Egypt Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Toxoid Vaccines in 2025
Figure 79. Manufacturing Process Analysis of Toxoid Vaccines
Figure 80. Industry Chain Structure of Toxoid Vaccines
Figure 81. Channels of Distribution
Figure 82. Global Toxoid Vaccines Sales Market Forecast by Region (2026-2031)
Figure 83. Global Toxoid Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Toxoid Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Toxoid Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Toxoid Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Toxoid Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Toxoid Vaccines
Figure 2. Toxoid Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Toxoid Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Toxoid Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Toxoid Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Toxoid Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Toxoid Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monovalent Tetanus Toxoid (TT)
Figure 12. Product Picture of Diphtheria
Figure 13. Product Picture of Tetanus
Figure 14. Product Picture of Pertussis (DTaP)
Figure 15. Product Picture of Diphtheria and Tetanus (DT)
Figure 16. Global Toxoid Vaccines Sales Market Share by Type in 2025
Figure 17. Global Toxoid Vaccines Revenue Market Share by Type (2020-2025)
Figure 18. Toxoid Vaccines Consumed in Hospitals and Clinics
Figure 19. Global Toxoid Vaccines Market: Hospitals and Clinics (2020-2025) & (K Units)
Figure 20. Toxoid Vaccines Consumed in Government Organizations
Figure 21. Global Toxoid Vaccines Market: Government Organizations (2020-2025) & (K Units)
Figure 22. Toxoid Vaccines Consumed in Research
Figure 23. Global Toxoid Vaccines Market: Research (2020-2025) & (K Units)
Figure 24. Toxoid Vaccines Consumed in Others
Figure 25. Global Toxoid Vaccines Market: Others (2020-2025) & (K Units)
Figure 26. Global Toxoid Vaccines Sale Market Share by Application (2024)
Figure 27. Global Toxoid Vaccines Revenue Market Share by Application in 2025
Figure 28. Toxoid Vaccines Sales by Company in 2025 (K Units)
Figure 29. Global Toxoid Vaccines Sales Market Share by Company in 2025
Figure 30. Toxoid Vaccines Revenue by Company in 2025 ($ millions)
Figure 31. Global Toxoid Vaccines Revenue Market Share by Company in 2025
Figure 32. Global Toxoid Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Toxoid Vaccines Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Toxoid Vaccines Sales 2020-2025 (K Units)
Figure 35. Americas Toxoid Vaccines Revenue 2020-2025 ($ millions)
Figure 36. APAC Toxoid Vaccines Sales 2020-2025 (K Units)
Figure 37. APAC Toxoid Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Europe Toxoid Vaccines Sales 2020-2025 (K Units)
Figure 39. Europe Toxoid Vaccines Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Toxoid Vaccines Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Toxoid Vaccines Revenue 2020-2025 ($ millions)
Figure 42. Americas Toxoid Vaccines Sales Market Share by Country in 2025
Figure 43. Americas Toxoid Vaccines Revenue Market Share by Country (2020-2025)
Figure 44. Americas Toxoid Vaccines Sales Market Share by Type (2020-2025)
Figure 45. Americas Toxoid Vaccines Sales Market Share by Application (2020-2025)
Figure 46. United States Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Toxoid Vaccines Sales Market Share by Region in 2025
Figure 51. APAC Toxoid Vaccines Revenue Market Share by Region (2020-2025)
Figure 52. APAC Toxoid Vaccines Sales Market Share by Type (2020-2025)
Figure 53. APAC Toxoid Vaccines Sales Market Share by Application (2020-2025)
Figure 54. China Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. India Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Toxoid Vaccines Sales Market Share by Country in 2025
Figure 62. Europe Toxoid Vaccines Revenue Market Share by Country (2020-2025)
Figure 63. Europe Toxoid Vaccines Sales Market Share by Type (2020-2025)
Figure 64. Europe Toxoid Vaccines Sales Market Share by Application (2020-2025)
Figure 65. Germany Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. France Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Toxoid Vaccines Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Toxoid Vaccines Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Toxoid Vaccines Sales Market Share by Application (2020-2025)
Figure 73. Egypt Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Toxoid Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Toxoid Vaccines in 2025
Figure 79. Manufacturing Process Analysis of Toxoid Vaccines
Figure 80. Industry Chain Structure of Toxoid Vaccines
Figure 81. Channels of Distribution
Figure 82. Global Toxoid Vaccines Sales Market Forecast by Region (2026-2031)
Figure 83. Global Toxoid Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Toxoid Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Toxoid Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Toxoid Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Toxoid Vaccines Revenue Market Share Forecast by Application (2026-2031)
